On the contrary, CD9 expression and CD9 MFI were steady in all AML subcompartments such as CD34+CD38− (P6), CD34+CD38dim (P7), and CD34+CD38+ (P8) AML cells (Figure 5C,D). This evidence concerns the gene CD34 and acute myeloid leukemia.